HP drug controller revokes suspension of Wockhardt drug

Pharmaceuticals firm Wockhardt Ltd today said Himachal Pradesh drug regulator has revoked the suspension imposed on sale and manufacturing of a combination medicine used for treatment of pain.
"The State Drug Controller, Himachal Pradesh, has now revoked the suspension and accordingly the company will continue to manufacture, sell and distribute the fixed dose combination (FDC) of cicyclomine hydrochloride IP 10mg, tramadol hydrochloride IP 50mg and acetamenophen IP 325mg," Wockhardt said in a filing to the BSE.
Last week, the company had said Himachal Pradesh state drug controller has suspended the manufacture, sale or distribution of the said FDC medicine.
Wockhardt had said in order to revoke the suspension, it was filing an appeal before the state government.

Reacting to the news, shares of Wockhardt Ltd jumped 13.47 per cent on the BSE in the afternoon trade to Rs 733 per scrip.